1C. Fukuda M, Mizuno M, Ono M, Mizuguchi K, Kominato S, Sato R, Miura T, Oikawa S, Hotta O, Ohte N
Effect of epipharyndeal abrasion therapy (EAT) on the remission of IgA nephritis/vasculitis
International Session, the 61st Annual meeting of Japanese Society of Nephroogy. Jun 8-10, 2018, Niigata, Japan

2C. Mizuguchi K, Fukuda M, Sato R, Ogiyama Y, Mizuno M, Ono M, Ohte N.
Demonstrating place of hyperuricemia in clinical scene on CKD. ISN FRONTIERS 2018 Feb 22-25,2018,Tokyo, Japan

3C. Sato R, Fukuda M, Ohta K, Ohte N
We should refrain from the first cannulation until at least 3 weeks after creation of Radio-Cephalic Arterio-Venous Fistula. ISN FRONTIERS 2018 Feb 22-25, 2018, Tokyo, Japan. “ISN Frontiers Meeting 2018 Top 10% Ranked Poster Award” 受賞

4C. Fukuda M, Sato R, Ogiyama Y, Miura T, Mizuno M, Ono M, Kobori H, Ohte N.
Restoration of Non-dipper type of circadian blood pressure rhythm during the tratment with HCTZ, ARB, and SGLT2i. ISN FRONTIERS 2018 Feb 22-25, 2018, Tokyo, Japan

5. Sato R, Sato T, Shirasawa Y, Kondo C, Fukuda M, Ohte N, Morozumi K
Therapeutic results of percutaneous transluminal angioplasty (PTA) using AngioSculpt PTA Scoring Balloon Catheter® for hemodialysis vascular access. Dialysis Access Symposium（DAS）2017 Oct 19-20, 2017, Nagoya, Japan

5C. Fuwa D, Fukuda M, Miura T, Ogiyama Y, Abe-Dohmae S, Kobori H, Ohte N Add-on HCTZ administration to ARB can achieve lower sodium balance in CKD patients. Kidney week 2015 Nov 3-8, 2015, San Diego,CA, USA

6C. Fukuda M, Miura T, Ogiyama Y, Sato R, Fuwa D, Ito H, Matsuoka T, Isobe-Sasaki Y, Kiyono K, Yamamoto Y, Hayano J, Ohte N
Azelnidipine can restore the deceleration capacity of heart rate variability (DC) in CKD patients with preceding treatment with ARB. Kidney week 2015 Nov 3-8, 2015, San Diego,CA, USA

7C. Miura T, Fukuda M, Watanabe S, Fuwa D, Sato R, Ogiyama Y, Isobe Y, Shirasawa Y, Yoshida A, Ohte N
Diuretic effect of ARB is not attributable to BP lowering during previous night, but to inhibition of tubular sodium reabsorption.
Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) June13-16, 2014, Athens, Greece

8C. Ogiyama Y, Fukuda M, Miura T, Fuwa D, Sato R, Isobe Y, Shirasawa Y, Yoshida A, Hayano J, Ohte N
Heart rate variability can be altered to indicate cardiac mortality as a function of renal dysfunction from an early- to end-stage of chronic kidney disease.
Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) June13-16, 2014, Athens, Greece

9C. Fuwa D, Miura T, Watanabe S, Ogiyama Y, Isobe Y, Yoshida A, Kobori H, Fukuda M, Ohte N
ARB can decrease intrarenal RAS activity resulting in restoration of non-dipper circadian BP rhythm.
Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH)
June13-16, 2014, Athens, Greece

10C. Fuwa D, Fukuda M, Sato R, Ogiyama Y, Isobe Y, Miura T, Shirasawa Y, Yoshida A, Kobori H, Doumae-Abe S, Ohte N
Effects of add-on administration of HCTZ to the preceding ARB treatment on sodium balance, circadian BP rhythm, and urinary angiotensinogen.
Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) June13-16, 2014, Athens, Greece

11C. Fukuda M, Miura T, Ogiyama Y, Fuwa D, Sato R, Isobe Y, Ohta K, Shirasawa Y, Sakata S, Fukuta H, Yoshida A, Yamamoto Y, et al.
Azelnidipine can restore the heart rate variability in CKD patients with preceding treatment with ARB.
Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) June13-16, 2014, Athens, Greece

12C. Watanabe S, Togawa H, Fuwa D, Isobe Y, Ogiyama Y, Miura T, Ichikawa T, Shirasawa Y, Fukuda M, Kimura.G
Night-time BP of <120/70 can improve the renal outcomes in patients with CKD. The American Society of Nephrology (ASN)
Nov 7-10, 2013, Atlanta, USA

13C. Fukuda M, Watanabe S, Fuwa D, Togawa H, Miura T, Hayano J
Azelnidipine attenuates the non-Gaussian heart rate variability in CKD patients with preceding treatment with ARB.
The American Society of Nephrology (ASN) Nov 7-10, 2013, Atlanta, USA

14C. Watanabe S, Fukuda M, Miura T, Kimura G
Lack of nocturnal BP-dip is a strong predictor of the renal dysfunction.
24th Scientific Meeting of the International Society of Hypertension. Sept 30-Oct 4, 2012, Sydney, Australia

15C. Miura T, Fukuda M, Sato R, Fukuta H, Watanabe S,Mizuno M, Sakata S, Kimura G.
Estimating autonomic nerve activity using ABPM in patients with CKD.
24th Scientific Meeting of the International Society of Hypertension. Sept 30-Oct 4, 2012, Sydney, Australia

16C. Fukuda M, Tomonari T, MiuraT, Kimura G.
Postural decreases in natriuresis can be used to detect diminished renal reserve leading to a non-dipper type of circadian BP rhythm.
24th Scientific Meeting of the International Society of Hypertension. Sept 30-Oct 4, 2012, Sydney, Australia

17C. Fukuda M, Yamanaka T, Mizuno M, Tomonari T, Miura T, Ichikawa T, Sota M, Shirasawa Y, Ito A, Yoshida A, Kimura G.
Night-time hypertension: Key to solve mysteries of cardio-renal connection.
International Society of Nephrology Nexus Symposium 2010.
April 15-18, 2010, Kyoto, Japan シンポジウム “Young Investigator Award”受賞

18. Yamamoto K, Takeda Y, Yamashita S, Sugiura T, Wakamatsu Y, Fukuda M, Ohte N, Dohi Y, Kimura G
Crucial role of kidney function in diurnal variation of endothelial function in essential hypertension.
ISH CANADA September 26-30, 2010, Vancouber, CAN

19C. Wakamatsu-Yamanaka T, Fukuda M, Mizuno M, Tomonari T, Miura T, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Kimura G Regional difference in the inhibitation of increasing rate of ESRD incidence within Japan.. ISH CANADA September 26-30, 2010, Vancouber, CAN

20C. Miura T, Fukuda M, Naito T, Tomonari T, Wakamatsu-Yamanata T, Mizuno M, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Kimura G.Circadian rhythms of urinary potassium and chloride excretion in patients with CKD. ISH CANADA September 26-30, 2010, Vancouber, CAN

21C. Fukuda M
シンポジウム Delayed nocturnal BP dip in CKD. JSH Japan-Korea International Symposium Oct 15-17, 2010, Fukuoka, Japan

22C. Fukuda M
シンポジウム Delayed nocturnal blood pressure dip in CKD.
International Symposium “Salt, Kidney and Circadian Blood Pressure Rhythm” Oct 29-30, 2010, Toba, Japan

23C. Fukuda M, Urushihara M, Wakamatsu-Yamanaka T, Kobori H, Kimura G
Intrarenal RAAS activity can modify circadian blood pressure rhythm in patients with IgA nephropathy.
ASN's 43rd Annual Meeting and Scientific Exposition. Nov 18-21, Denver, CO, USA (Oral presentation)

24C. Mizuno M, Fukuda M, Yamanaka T, Tomonari T, Ichikawa T, Nishio T, Miyagi S, Shirasawa Y, Motokawa M, Yoshida A, Kimura G.
Sustained type of morning hypertension (MH) is a subclass of non-dipper requiring longer duration until BP falls during night.
The 22nd Scientific Meeting International Society of Hypertension, and the 18th Scientific Meeting European Society of Hypertension. June 14-19, 2008, Berlin, Germany

25. Yamamoto K, Takeda Y, Yamashita S, Sugiura T, Wakamatsu Y, Fukuda M, Dohi Y, Kimura G.
Endothelial dysfunction as one mechanism to cause cardio-renal connection in hypertension.
The 22nd Scientific Meeting International Society of Hypertension, and the 18th Scientific Meeting European Society of Hypertension. June 14-19, 2008, Berlin, Germany

26C. Fukuda M, Yamanaka T, Mizuno M, Tomonari T, Ichikawa T, Shirasawa Y, Nishio T, Miyagi S, Motokawa M, Yoshida A, Kimura G.
Olmesartan (Olm) shortens the duration until night-time blood pressure (BP) dip and normalizes circadian BP rhythm from non-dipper to dipper in CKD.
The 22nd Scientific Meeting International Society of Hypertension, and the 18th Scientific Meeting European Society of Hypertension. June 14-19, 2008, Berlin, Germany

27C. Fukuda M, Mizuno M, Yamanaka T, Tomonari T, Ichikawa T, Shirasawa Y, Nishio T, Miyagi S, Motokawa M, Yoshida A, Kimura G
Renal dysfunction requires longer duration until night-time blood pressure (BP) dips.
The 22nd Scientific Meeting International Society of Hypertension, and the 18th Scientific Meeting European Society of Hypertension. June 14-19, 2008, Berlin, Germany

28C. Fukuda M, Mizuno M, Yamanaka T, Nishio T, Miyagi S, Shirasawa Y, Motokawa M, Yoshida A, Kimura G
Renal dysfunction requires longer duration before blood pressure (BP) dips during night.
Renal week 2007 (40th Annual Meeting and Scientific Exposition of American Society of Nephrology).Nov 2-5, 2007, San Francisco, USA

29C. Fukuda M, Mizuno M, Yamanaka T, Nishio T, Miyagi S, Shirasawa Y, Motokawa M, Yoshida A, Kimura G
Olmesartan shortens the duration until nocturnal blood pressure (BP) dip and normalizes circadian BP rhythm from non-dipper to dipper in CKD.
Renal week 2007 (40th Annual Meeting and Scientific Exposition of American Society of Nephrology) Oral presentation. Nov 2-5, 2007, San Francisco, USA

30C. Miyagi S, Fukuda M, Motokawa M, Kato N, Shirasawa Y, Nishio T, Sengo K, Muramatsu W, Usami T, Oikawa T, Yoshida A, Kimura G
Morning hypertension accompanied with kidney dysfunction is based on sustained rather than surge type.
The 21st Scientific Meeting of the International Society of Hypertension, 5th Asian-Pacific Congress of Hypertension,
29th Annual Scientific Meeting of the Japanese Society of Hypertension Oct 15-19, 2006, Fukuoka, Japan

31C. Fukuda M, Motokawa M, Kato N, Shirasawa Y, Nishio T, Miyagi S, Sengo K, Muramatsu W, Usami T, Oikawa T, Yoshida A, Kimura G
Renal dysfunction requires longer duration before blood pressure dips during night: Hypothesis on renal mechanism of non-dipper.
The 21st Scientific Meeting of the International Society of Hypertension, 5th Asian-Pacific Congress of Hypertension,
29th Annual Scientific Meeting of the Japanese Society of Hypertension. Oct 15-19, 2006, Fukuoka, Japan

32C. Fukuda M, Usami T, Shirasawa Y, Miyagi S, Nishio T, Muramatsu W, Sengo K, Kato N, Yoshida A, Kimura G
Low birth weight and end-stage renal disease: Demographic analysis by region in Japan. Motokawa M,
The 21st Scientific Meeting of the International Society of Hypertension, 5th Asian-Pacific Congress of Hypertension,
29th Annual Scientific Meeting of the Japanese Society of Hypertension. Oct 15-19, 2006, Fukuoka, Japan

33C. Fukuda M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Muramatsh W, Sengo K, Kato N, Usami T, Oikawa T, Yoshida A, Kimura G
Plasma aldosterone to renin activity ratio is influenced by kidney dysfunction.
The 21st Scientific Meeting of the International Society of Hypertension, 5th Asian-Pacific Congress of Hypertension,
29th Annual Scientific Meeting of the Japanese Society of Hypertension. Oct 15-19, 2006, Fukuoka, Japan

34C. Fukuda M, Motokawa M, Kato N,Shirasawa Y, Nishio T, Miyagi S, Sengo K, Muramatsu W, Usami T, Oikawa T, Yoshida A, et al.
Mapping of blood pressure in Japan: Relation to regional differences in salt intake and stroke.
The 21st Scientific Meeting of the International Society of Hypertension, 5th Asian-Pacific Congress of Hypertension,
29th Annual Scientific Meeting of the Japanese Society of Hypertension. Oct 15-19, 2006, Fukuoka, Japan Oral presentation

35C. Fukuda M, Motokawa M, Kato N, Shirasawa Y, Nishio T, Miyagi S, Sengo K, Muramatsu W, Usami T, Oikawa T, Yoshida A, et al.
シンポジウム Mapping of blood pressure in Japan: Relation to regional differences in salt intake and stroke.
International Symposium "Salt, Other Minerals and Hypertension" Oct 19-20, 2006, Nagoya, Japan

36C. Fukuda M, Motokawa M, Kato N, Shirasawa Y, Nishio T, Miyagi S, Sengo K, Muramatsu W, Usami T, Oikawa T, Yoshida A, Kimura G シンポジウム Diminished kidney’s capability to excrete salt makes circadian blood pressure rhythm non-dipper, enhancing compensatory pressure-natriuresis during night. International Symposium "Salt, Other Minerals and Hypertension" Oct 19-20, 2006, Nagoya, Japan

37C. Fukuda M, Motokawa M, Miyagi S, Shirasawa Y, Sengo K, Nishio T, Usami T, Yoshida A, Kimura G.
Low birth weight and end-stage renal disease: Demographic analysis by region in Japan.
Renal week 2006 (39th Annual Meeting and Scientific Exposition of American Society of Nephrology)
Nov 16-19, 2006, San Diego, California, USA

38C. Fukuda M, Kato N, Motokawa M, Miyagi S, Shirasawa Y, Sengo K, Nishio T, Usami T, Yoshida A, Kimura G.
Olmesartan restores nocturnal blood pressure decline possibly by enhancing diurnal sodium excretion into urine.
Renal week 2006 (39th Annual Meeting and Scientific Exposition of American Society of Nephrology)
Nov 16-19, 2006, San Diego, California, USA

39C. Fukuda M, Motokawa M, Kato N, Miyagi S, Sengo K, Muramatsu W, Usami T, Yoshida A, Okayama A, Kimura G
Mapping of blood pressure (BP) in Japan: Relation to regional differences in salt intake and stroke.
ASN (American Society of Nephrology) 38th Annual Renal Week Meeting. Nov 10 - 13, 2005 , Philadelphia, USA

40C. Fukuda M, Motokawa M, Kato N, Miyagi S, Sengo K, Muramatsu W, Usami T, Yoshida A, Kimura G Renal dysfunction requires longer duration before blood pressure (BP) dips during night: Hypothesis on renal mechanism of non-dipper.
ASN (American Society of Nephrology) 38th Annual Renal Week Meeting. Nov 10 - 13, 2005, Philadelphia, USA

41C. Fukuda M, Motokawa M, Kato N, Usami T, Yoshida A, Kimura G
Nocturnal polyuria is based on osmotic diuresis, but not on water diuresis in chronic kidney disease (CKD).
American Society of Nephrology 37th Annual Meeting & Scientific Exposition. Oct 29-Nov 1, 2004, St. Louis, Missouri, USA

42. Usami T, Kato N, Nakao N, Fukuda M, Takeuchi O, Kamiya Y, Yoshida A, Kimura G
Shift of regional distribution of end-stage renal disease in Japan after appearance of angiotensin-converting enzyme inhibitors.
American Society of Nephrology 36th Annual Meeting & Scientific Exposition, Nov 12-17, 2003, San Diego, USA

43C. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, Yoshida A, Kimura G Nocturnal blood pressure is elevated with enhanced natriuresis and proteinuria during night as renal function deteriorates in nephropathy.
American Society of Nephrology 36th Annual Meeting & Scientific Exposition, Nov 12-17, 2003, San Diego, USA

44. Yoshida A, Takeda A, Fukuda M, Ohtsuka Y, Morozumi K
Clinical study of choresterol shower emboli. 20th International Leageu Arthritis Rheumatism Aug 25-29, 2001, Edmonton Canada

45. Yoshida A, Morozumi K, Takeda A, Fukuda M, Toda S
Clinical effects of trandolapril in chronic glomerulonephritis patients with renal insufficiency.
37th Congress of European Dialysis and Transplantation Association (EDTA) Sept 22-26, 2000, Niece, France

46C. Fukuda M, Oikawa T, Takeda A, Morozumi K
Capillary expression of Tenascin in Chronic Renal Allograft. Fourth Banff Conference on Allograft Pathology March 7-12, Banff, Alberta, Canada

47. Takeda A, Morozumi K, Koyama K, Yoshida A, Uchida K, Tominaga Y, Haba T, Fukuda M, et al.
Severe cyslosporine arteriopathy with focal segmental glomerulosclerosis is not a fatal finding to chronic renal allograft failure after 5th year of transplantation using cyclosporine. XVI International Congress of the Transplantation Society Aug 25-30, 1996, Barcelona, Spain

48. Morozumi K, Fukuda M, Oikawa T, Sugito K, Takeuchi O, Usami T, Fujinami T, Takeda A, Koyama K, Yoshida A, Uchida K, et al.
A new histopathological diagnostic criterion for chronic rejection will contribute to improve the long out-come of renal allografts in cyclosporine era.
XVI International Congress of the Transplantation Society Aug 25-30, 1996, Barcelona, Spain

49. Oda A, Morozumi K, Kodera K, Sugito K, Takeuchi O, Fukuda M, et al.
Is late graft biopsy available for predicting the long outcome of renal allograft?
The Third Congress of Asian Society of Transplantation. Dec 12.4-12.6, 1993, Bangkok, Thailand

1.福田　道雄、村田実奈子、伊藤祐基、田川英昇、浅井伸夫、上野岳洋、美浦利幸、清野健
一宮西病院腎臓内科、増子クリニック昴、大阪大学基礎工学研究科機能創生専攻生体工学領域
血液透析による体液減少により末梢血管抵抗は減じる
第46回日本高血圧学会総会, 2024.10.12-14, 福岡

2.村田　実奈子1、福田　道雄2、美浦　利幸2、佐藤　麻由1、上野　岳洋1、木元　裕実1、田川　英昇1、清野　健3
1増子記念病院、2一宮西病院、3大阪大学大学院基礎工学研究科
血液透析患者の塩分摂取量が多いと交感神経活動度が亢進するのか？
第67回日本腎臓学会学術総会, 2024.6.28-30, 横浜

3.福田　道雄1、美浦　利幸1、村田　実奈子2、佐藤　麻由2、上野　岳洋2、田川　英昇2、清野　健3
1一宮西病院、2増子記念病院、3大阪大学大学院基礎工学研究科血液透析中の血圧に影響する因子の検索
第67回日本腎臓学会学術総会, 2024.6.28-30, 横浜

4.シンポジウム21. 透析患者の心血管障害を再考する！～透析患者におけるアンジオテンシン受容体ネプリライシン阻害薬への期待
中山 貴文:1,2, 福田 道雄:3, 両角 國男:3, 瀬尾 由広:1,2
1:（医）衆済会増子記念病院循環器内科, 2:名古屋市立大学循環器内科学, 3:（医）衆済会増子記念病院腎臓内科
第69回日本透析医学会, 2024.6.7-9, 横浜

5.福田 道雄:1,2,3, 村田 実奈子:2,3, 岩井 祐子:2, 美浦 利幸:1, 上野 岳洋:2, 佐藤 麻由:2, 鹿島 伸康:2, 田川 英昇:2, 浅井 伸夫:2, 中山 貴文:2, 清野 健:2,3
1:一宮西病院腎＆シャント・レミッションセンター, 2:増子記念病院クリニック昴, 3:大阪大学大学院基礎工学研究科
心エコーに焦点を当てた透析中の突発的過降圧の検討
第69回日本透析医学会, 2024.6.7-9, 横浜

6.村田 実奈子:1,3, 福田 道雄:1,2,3, 岩井 祐子:1, 上野 岳洋:1, 美浦 利幸:2, 伊藤 祐基:2, 佐藤 麻由:1, 中西 祐子:1, 木元 裕実:1, 鹿島 伸康:1,3, 田川 英昇:1, 浅井 伸夫:1, 木下 裕子:1, 清野 健:1,3
1:増子記念病院クリニック昴, 2:一宮西病院腎内, 3:大阪大学大学院基礎工学研究科
心拍変動λに焦点を当てた透析中の突発的過降圧の検討
第69回日本透析医学会, 2024.6.7-9, 横浜

7.美浦 利幸，福田 道雄，村田 実奈子，山﨑 親雄.
血漿遊離ﾒﾀﾈﾌﾘﾝ分画は透析患者の褐色細胞腫診断に有用である。
第45回日本高血圧学会総会, 2023.9.15-17, 大阪

8.福田道雄, 美浦利幸, 村田美奈子, 浅井伸夫, 田川英昇, 上野岳洋, 清野健, 山﨑親雄
血液透析における循環血漿量・交感/副交感神経が血圧に及ぼす影響
第45回日本高血圧学会総会, 2023.9.15-17, 大阪

9C. 村田実奈子，福田道雄, 浅井伸夫，田川英昇，上野岳洋，鹿島伸康, 美浦利幸, 鈴木茂，木下裕子，清野健, 山崎親雄
透析終盤の血圧上昇と交感神経・副交感神経活動度の関係.
第68回日本透析医学会, 2023.6.16-18,神戸

10C. 村田実奈子，福田道雄，西村美里，田川英昇，木元裕実， 上野岳洋，鹿島伸康，只腰雅夫，木下裕子，山崎親雄
PTA治療に伴うVAPR値の変化の検討.
第68回日本透析医学会, 2023.6.16-18,神戸